GoodRx Holdings, Inc. (NASDAQ: GDRX) reported Q4 EPS of $0.09, in-line with the analyst estimate of $0.09. Revenue for the quarter came in at $194.8 million versus the consensus estimate of $193.43 million.

GUIDANCE:

GoodRx Holdings, Inc. sees FY2026 revenue of $750-780 million, versus the consensus of $815.9 million.

For earnings history and earnings-related data on GoodRx Holdings, Inc. (GDRX) click here.